Maggi row: Nestle moves Bombay HC against ban

Other MNC withdraws noodle product that was awaiting product licence

GN Bureau | June 11, 2015


#maggie   #noodles   #nestle   #bombay high court   #hindustan lever  

After voluntarily withdrawing Maggi noodles from the market, Nestle India, now buoyed by clearance from Singapore has on Thursday approached Bombay High Court against ban on Maggi noodles.

Last week, FSSAI had banned nine variants of Maggi terming them "unsafe and hazardous" for human consumption after finding high levels of lead and presence of taste enhancer monosodium glutamate (MSG). Nestle India also announced withdrawal of the product from the market.

Meanwhile, Goa's Food and Drugs Administration has sent the noodle samples for a third test. Goa FDA had given a clean chit to the instant noodles after it had found lead below the permissible level and no monosodium glutamate (MSG) in the samples that it had analysed. But FSSAI had dismissed the report as "questionable".

The third test, samples for which were couriered on Wednesday to Mysuru's Central Food Technological Research Institute, is to restore "credibility" of the state laboratory where Maggi noodles was examined first by Goa FDA. The report is expected in within eight to 10 days.

Maharashtra FDA, which showed negligible lead content in 15 out of 20 samples, is not going for any counter-verification test as "FSSAI has already ordered a national recall".

Kerala had cleared Maggi noodles after two tests and is now testing other brands.

In another related development, Hindustan Unilever Limited (HUL) has decided to recall its Chinese range of 'Knorr' instant noodles from the market pending product approval from the FSSAI.

"HUL has decided to stop production and sale of its Chinese range of instant noodles till such time as its application is approved by FSSAI. HUL is initiating a withdrawal of its Chinese instant noodles from the market," HUL said in a statement.

It, however, made it clear that "the discontinuance of manufacturing and sale of Chinese instant noodles is not on account of any safety or quality concerns." The FSSAI on Monday issued an order to test more brands of noodles, pastas and macaronis.

It listed 33 items manufactured by seven companies approved by it in these categories, wherein HUL's Chinese range of 'Knorr' instant noodles did not feature.

HUL said it had submitted an application with FSSAI for product approval for the Knorr Chinese range of instant noodles in February 2015.

Comments

 

Other News

WAVES Summit: A Global Media Powerhouse

In 2019, at the inauguration of National Museum of Indian Cinema, prime minister Narendra Modi had expressed his wish to have a forum of global repute similar to the World Economic Forum, Davos, for India’s media and entertainment (M&E) industry. That wish became reality with the WAVES Summit in

India’s silent lead crisis

Flint, Michigan, was a wake-up call. Lead contamination in water supplied to homes in that American city led to a catastrophic public health emergency in 2014, which is yet to be fully resolved. But India’s lead poisoning crisis is ten times worse- larger, quieter, and far most devastating. Nearly ha

‘Dial 100’: A tribute to the police force and its unsung heroes

Dial 100  By Kulpreet Yadav HarperCollins, 232 pages, Rs 299  A wife conspires with her ex-lover to mur

India’s economic duality: formal dreams, informal realities

“Whatever you can rightly say about India, the opposite is also true.” – Joan Robinson In its pursuit of becoming a $5 trillion economy, India has laid significant emphasis on formalizing its economic architecture—expanding digital payments, mandating

Targeting root causes of cancer with green policies

The Budget 2025 was splashed across headlines with its innumerable numbers and policies, but lurking behind the balance sheets is a threat that it has not accounted for yet — the silent, merciless clutches of cancer. The World Health Organisation (WHO) states that it remains one of humanity`s mo

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter